PINNACLE ASSOCIATES LTD - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PINNACLE ASSOCIATES LTD ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$135,000
-36.9%
35,630
-15.1%
0.00%
-20.0%
Q4 2019$214,000
-96.6%
41,980
-96.7%
0.01%
-96.7%
Q3 2019$6,355,000
-20.7%
1,257,098
-3.2%
0.15%
-20.2%
Q2 2019$8,013,000
+21.8%
1,298,723
-8.4%
0.19%
+26.2%
Q1 2019$6,581,000
+8.5%
1,418,391
-1.8%
0.15%
-5.1%
Q4 2018$6,068,000
-36.8%
1,444,866
-5.6%
0.16%
-21.1%
Q3 2018$9,597,000
-33.3%
1,530,657
-14.4%
0.20%
-32.8%
Q2 2018$14,384,000
-8.3%
1,789,073
-14.9%
0.30%
-3.6%
Q1 2018$15,678,000
+19.1%
2,101,668
-5.0%
0.31%
+21.3%
Q4 2017$13,168,000
-25.0%
2,213,118
-7.2%
0.25%
-21.9%
Q3 2017$17,552,000
+5.3%
2,384,833
-2.9%
0.32%
+1.2%
Q2 2017$16,669,000
-30.8%
2,454,918
-3.9%
0.32%
-30.4%
Q1 2017$24,104,000
+4.7%
2,553,438
-4.2%
0.46%
-1.1%
Q4 2016$23,025,000
+29.2%
2,664,940
-5.3%
0.46%
+30.3%
Q3 2016$17,816,000
+48.4%
2,814,540
-1.1%
0.36%
+37.8%
Q2 2016$12,006,0002,844,9200.26%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
ARDSLEY ADVISORY PARTNERS LP 1,255,000$5,823,0001.12%
Phocas Financial Corp. 1,146,292$5,319,0000.54%
Worth Venture Partners, LLC 138,357$641,0000.36%
RICE HALL JAMES & ASSOCIATES, LLC 2,293,179$10,640,0000.34%
Monashee Investment Management LLC 240,000$1,114,0000.26%
BKS ADVISORS, LLC 118,587$550,0000.22%
PINNACLE ASSOCIATES LTD 1,418,391$6,581,0000.15%
FARALLON CAPITAL MANAGEMENT LLC 4,200,820$19,492,0000.15%
Fosun International Ltd 472,580$2,174,0000.14%
CARILLON TOWER ADVISERS, INC. 3,948,024$18,318,0000.13%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders